Sugammadex and the Risk of Unintended Pregnancy in Women With Vascular Anomalies, An Alert for the Team
(2026) Journal of Vascular Anomalies — Vol. 7, n° 1, p. e138 (2026)
Files
sugammadex_and_the_risk_of_unintended_pregnancy_in.5.pdf
Open Access - Adobe PDF
- 256.95 KB
Details
- Authors
- Abstract
- This article highlights a clinically relevant and under-recognized issue: the potential interaction between sugammadex, an increasingly used anesthesia medication, and hormonal contraceptives in women with vascular anomalies receiving teratogenic therapies. With many of these women undergoing repeated procedures under general anesthesia and concurrently receiving agents such as sirolimus or thalidomide, there is a pressing need for heightened awareness around contraceptive efficacy and risk mitigation.
- Affiliations
Citations
Thirion, C., Docquier, M.-A., Coulie, J., Smajda, S., Hammer, F., Boon, L., & Seront, E. (2026). Sugammadex and the Risk of Unintended Pregnancy in Women With Vascular Anomalies, An Alert for the Team. Journal of Vascular Anomalies, 7(1), e138. https://doi.org/10.1097/jova.0000000000000138 (Original work published 2026)